Fig. 2
From: Salivary chemokines and growth factors in patients with ischemic stroke
Concentration of chemokines in non-stimulated saliva of stroke patients compared to controls. MCP-1/CCL2: monocyte chemoattractant protein-1/chemokine ligands 2; MIP-1α/CCL3: macrophage inflammatory protein 1alpha/chemokine ligands 3; MIP-1β/ CCL4: macrophage inflammatory protein 1beta/chemokine ligands 4; MCP-3/CCL7: monocyte chemoattractant protein-3/chemokine ligands 7; eotaxin/CCL11: eotaxin/chemokine ligand 11; CTACK/CCL27: cutaneous T-cell-attracting chemokine/chemokine ligands 27; GRO-α/ CXCL1: growth-regulated alpha protein/chemokine (C-X-C motif) ligand 1; IL-8/CXCL8: interleukin 8/chemokine (C-X-C motif) ligand 8; MIG/CXCL9: monokine induced by gamma interferon/chemokine (C-X-C motif) ligand 9; IP-10/CXCL10: interferon gamma-induced protein 10/chemokine (C-X-C motif) ligand 10; SDF-1alpha/CXCL12: stromal cell-derived factor 1/chemokine (C-X-C motif) ligand 12; MIF: macrophage migration inhibitory factor; **p < 0.01; ***p < 0.001; ****p < 0.0001.
